NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Dr. Bala, it is a shame that you & I have to keep repeating ourselves, and keep explaining why UCLA is saying ATL-DC instead of DCVax-L for the combination trial with Pembrolizumab (Keytruda).

Some posters are purposely trying to confuse & confound newbies, and trying to suggest that there is a wedge between NWBio & UCLA.

Thankfully, I do not believe many on this board are falling for this tactic. The fact that they are grasping for make-believe straws is a bullish sign in my opinion.

It tell me that top line data release is very near, and the Bears are in panic mode.